Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-25

FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approves a supplemental application for albuterol sulfate submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol sulfate (Albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE (ALBUTEROL SULFATE)